PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 112 filers reported holding PROVENTION BIO INC in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $991,715 | -82.5% | 41,150 | -92.3% | 0.00% | -100.0% |
| Q4 2022 | $5,653,534 | +4650.9% | 534,866 | +1920.4% | 0.00% | – |
| Q3 2022 | $119,000 | +26.6% | 26,473 | +13.0% | 0.00% | – |
| Q2 2022 | $94,000 | -94.3% | 23,419 | -89.7% | 0.00% | – |
| Q1 2022 | $1,659,000 | +1282.5% | 226,708 | +967.2% | 0.00% | – |
| Q4 2021 | $120,000 | -23.6% | 21,244 | -13.8% | 0.00% | – |
| Q3 2021 | $157,000 | -16.9% | 24,658 | +10.4% | 0.00% | – |
| Q2 2021 | $189,000 | +23.5% | 22,345 | +53.3% | 0.00% | – |
| Q1 2021 | $153,000 | -97.4% | 14,576 | -95.7% | 0.00% | -100.0% |
| Q4 2020 | $5,790,000 | +24.4% | 341,823 | -5.8% | 0.00% | 0.0% |
| Q3 2020 | $4,653,000 | -21.8% | 362,703 | -14.0% | 0.00% | 0.0% |
| Q2 2020 | $5,949,000 | +27.4% | 421,619 | -16.9% | 0.00% | 0.0% |
| Q1 2020 | $4,669,000 | +104.9% | 507,485 | +231.8% | 0.00% | +100.0% |
| Q4 2019 | $2,279,000 | – | 152,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |